Overexpression of calmodulin in pancreatic beta cells induces diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2008-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2006121358PMID 18525005PMCID PMC2518429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mouse models of diabetic nephropathy.

  2009cited by this paper
• Stacking the deck for drug discovery in diabetic nephropathy: in search of an animal model.

  2008cited by this paper
• Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

  2007cited by this paper
• Protection of pancreatic beta-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies.

  2007cited by this paper
• Protection of pancreatic β-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies

  2007cited by this paper
• Altered Endothelial Nitric Oxide Synthase Targeting and Conformation and Caveolin-1 Expression in the Diabetic Kidney

  2006cited by this paper
• Uncoupling of vascular endothelial growth factor with nitric oxide as a mechanism for diabetic vasculopathy.

  2006cited by this paper
• Growth factor midkine is involved in the pathogenesis of diabetic nephropathy.

  2006cited by this paper
• Nephron number and renal risk in hypertension and diabetes.

  2005cited by this paper
• Mouse models of diabetic nephropathy.

  2005cited by this paper
• Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice

  2005cited by this paper
• Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice.

  2005cited by this paper
• Diabetic nephropathy: Linking histology, cell biology, and genetics.

  2004cited by this paper
• The role of vascular endothelial growth factor (VEGF) in renal pathophysiology.

  2004cited by this paper
• Rapid change of glucose concentration promotes mesangial cell proliferation via VEGF: inhibitory effects of thiazolidinedione.

  2004cited by this paper
• Model of robust induction of glomerulosclerosis in mice: importance of genetic background.

  2003cited by this paper
• Remission and regression of diabetic nephropathy.

  2003cited by this paper
• Overview of glucose signaling in mesangial cells in diabetic nephropathy.

  2003cited by this paper
• Resistance to glomerulosclerosis in B6 mice disappears after menopause.

  2003cited by this paper
• Paradoxes of nitric oxide in the diabetic kidney.

  2003cited by this paper
• Nitric oxide modulates vascular disease in the remnant kidney model.

  2002cited by this paper
• Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.

  2002cited by this paper
• Calmodulin Overexpression Causes Ca2+-Dependent Apoptosis of Pancreatic β Cells, Which Can Be Prevented by Inhibition of Nitric Oxide Synthase

  2002cited by this paper
• Vascular endothelial growth factor is expressed in endothelial cells isolated from skeletal muscles of nitric oxide synthase knockout mice during prazosin-induced angiogenesis.

  2002cited by this paper
• Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: effects of ACEI and ARB.

  2002cited by this paper
• Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.

  2001cited by this paper
• Endothelial Cell Dysfunction Leading to Diabetic Nephropathy: Focus on Nitric Oxide

  2001cited by this paper
• Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.

  2001cited by this paper
• Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.

  2001cited by this paper
• Role of vascular endothelial growth factor in diabetic nephropathy.

  2000cited by this paper
• Ultrastructural characteristics of diabetic nephropathy

  2000cited by this paper
• Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC β inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes

  2000cited by this paper
• Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro.

  1999cited by this paper
• Molecular mechanisms of diabetic renal hypertrophy.

  1999cited by this paper
• Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy

  1998cited by this paper
• Strain differences rather than hyperglycemia determine the severity of glomerulosclerosis in mice.

  1998cited by this paper
• Ultrastructural and functional analyses of nephropathy in calmodulin‐induced diabetic transgenic mice

  1997cited by this paper
• Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

  1997cited by this paper
• Magnitude of end-stage renal disease in IDDM: a 35 year follow-up study.

  1996cited by this paper
• Declining incidence of nephropathy in insulin-dependent diabetes mellitus.

  1994cited by this paper
• Antibody-mediated redistribution and shedding of endothelial antigens in the rabbit.

  1993cited by this paper
• Elevated beta-cell calmodulin produces a unique insulin secretory defect in transgenic mice.

  1992cited by this paper
• Calmodulin-induced early-onset diabetes in transgenic mice.

  1989cited by this paper
• On the renal basis for essential hypertension: nephron heterogeneity with discordant renin secretion and sodium excretion causing a hypertensive vasoconstriction-volume relationship.

  1988cited by this paper
• Hemodynamically mediated glomerular injury and the progressive nature of kidney disease.

  1983cited by this paper
• Hemodynamically mediated glomerular injury and the progressive nature of kidney disease.

  1983cited by this paper
• Determination of membrane thickness distribution from orthogonal intercepts

  1979cited by this paper
• J Am Soc Nephrol 12: 993–1000, 2001 Antibodies against Vascular Endothelial Growth Factor Improve Early Renal Dysfunction in Experimental Diabetes

  year unknowncited by this paper

• The Effect of Selected Nitric Oxide Synthase Polymorphisms on the Risk of Developing Diabetic Nephropathy

  2024cites this paper
• Identification of adipose tissue transcriptomic memory of anorexia nervosa

  2023cites this paper
• Metabolomic Analysis of Serum and Tear Samples from Patients with Obesity and Type 2 Diabetes Mellitus

  2022cites this paper
• Experimental Animal Models of Diabetic Kidney Disease

  2020cites this paper
• Diabetic Kidney Disease

  2020cites this paper
• Exaggerated renal fibrosis in lncRNA Gas5-deficient mice after unilateral ureteric obstruction.

  2020cites this paper
• improves renal endothelial function in obese Zucker rats on a high-salt diet

  2019cites this paper
• Liraglutide Improves Renal Endothelial Function in Obese Zucker Rats on a High-Salt Diet

  2019cites this paper
• Pathology of the Kidney in Diabetes

  2018cites this paper
• Animal Models of Diabetic Kidney Disease

  2018cites this paper
• Modelling diabetic nephropathy in mice

  2018cites this paper
• Mechanisms of metabolic memory and renal hypoxia as a therapeutic target in diabetic kidney disease

  2017cites this paper
• An Update on the Use of Animal Models in Diabetic Nephropathy Research

  2016cites this paper
• Protective effect of hydrogen sulfide on pancreatic beta-cells.

  2015cites this paper
• Recent Advances in Animal Models of Diabetic Nephropathy

  2014cites this paper
• Semaphorin3a Promotes Advanced Diabetic Nephropathy

  2014cites this paper
• Role of Endothelial Nitric Oxide Synthase in Diabetic Nephropathy: Lessons from Diabetic eNOS Knockout Mice

  2014cites this paper
• Calmodulin as a universal regulator of voltage gated calcium channels

  2014cites this paper
• [Role of hydrogen sulfide in chronic kidney disease and diabetic nephropathy].

  2012cites this paper
• Distribution of hydrogen sulfide (H2S)-producing enzymes and the roles of the H2S donor sodium hydrosulfide in diabetic nephropathy

  2012cites this paper
• A Diachronic Study of Diabetic Nephropathy in Two Autochthonous Lines of Rats to Understand Diabetic Chronic Complications

  2011cites this paper
• Cardiovascular , Pulmonary and Renal Pathology Diabetic Albuminuria Is Due to a Small Fraction of Nephrons Distinguished by Albumin-Stained Tubules and Glomerular Adhesions

  2010cites this paper
• Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse

  2010cites this paper
• Stacking the deck for drug discovery in diabetic nephropathy: in search of an animal model.

  2008cites this paper